WEBVTT

00:00:02.802 --> 00:00:03.370
 ♪♪

00:00:17.650 --> 00:00:19.719
>> THE INDIANAPOLIS BUSINESS

00:00:19.786 --> 00:00:20.954
JOURNAL NAMED FISHERS-BASED

00:00:21.020 --> 00:00:22.288
GENEZEN THE #1 FASTEST GROWING

00:00:22.355 --> 00:00:24.124
COMPANY IN INDIANAPOLIS IN 2020.

00:00:24.190 --> 00:00:27.660
GENEZEN IS NOW INVESTING

00:00:27.727 --> 00:00:28.962
40-MILLION DOLLARS TO TRIPLE ITS

00:00:29.028 --> 00:00:31.164
FOOTPRINT IN THE CROSSPOINT

00:00:31.231 --> 00:00:32.198
BUSINESS PARK.

00:00:32.265 --> 00:00:33.333
BUSINESS OF HEALTH REPORTER

00:00:33.400 --> 00:00:37.670
KYLIE VELETA HAS MORE.

00:00:37.737 --> 00:00:37.904
KYLIE.

00:00:37.971 --> 00:00:39.606
>> THANK YOU VERY MUCH, GERRY.

00:00:39.672 --> 00:00:40.240
GENEZEN IS JUST ONE PIECE OF A

00:00:40.306 --> 00:00:40.907
RECENT LIFE SCIENCES BUSINESS

00:00:40.974 --> 00:00:42.208
BOOM IN FISHERS. THE CITY HAS

00:00:42.275 --> 00:00:43.743
ATTRACTED MORE THAN

00:00:43.810 --> 00:00:45.111
500-MILLION-DOLLARS IN NEW

00:00:45.178 --> 00:00:46.212
INVESTMENTS IN THE PAST 12

00:00:46.279 --> 00:00:48.181
MONTHS.

00:00:48.248 --> 00:00:49.282
JUST DAYS AGO, THE CONTRACT

00:00:49.349 --> 00:00:50.283
DEVELOPMENT AND MANUFACTURING

00:00:50.350 --> 00:00:51.284
ORGANIZATION' OPENED THE FIRST

00:00:51.351 --> 00:00:53.787
PHASE OF ITS 40-MILLION-DOLLAR

00:00:53.853 --> 00:00:54.888
EXPANSION: A NEW RESEARCH AND

00:00:54.954 --> 00:00:55.889
DEVELOPMENT LAB.

00:00:55.955 --> 00:00:56.790
JOINING ME NOW TO TELL US MORE

00:00:56.856 --> 00:00:57.757
ABOUT THE COMPANY'S VISION FOR

00:00:57.824 --> 00:00:58.825
THE FUTURE IS GENEZEN'S NEW

00:00:58.892 --> 00:00:59.859
CHIEF EXECUTIVE OFFICER, RAY

00:00:59.926 --> 00:01:03.129
KACZMAREK.

00:01:03.196 --> 00:01:05.131
AND RAY, I SHOULD SAY, WELCOME

00:01:05.198 --> 00:01:05.999
TO THE HOOSIER STATE.

00:01:06.065 --> 00:01:08.301
I UNDERSTAND YOU JUST JOINED THE

00:01:08.368 --> 00:01:09.602
TEAM IN SEPTEMBER.

00:01:09.669 --> 00:01:11.671
>> YES, I JUST JOINED THE TEAM.

00:01:11.738 --> 00:01:16.543
CAME HERE OUT OF SAN DIEGO,

00:01:16.609 --> 00:01:18.611
CALIFORNIA, HAPPY TO BE A

00:01:18.678 --> 00:01:19.045
HOOSIER

00:01:19.112 --> 00:01:22.315
>> LET'S START WHAT GENEZEN

00:01:22.382 --> 00:01:25.151
SPECIALIZES IN, CELL AND GENE

00:01:25.218 --> 00:01:25.418
THERAPY.

00:01:25.485 --> 00:01:28.288
CAN YOU EXPLAIN WHY IT IS SUCH

00:01:28.354 --> 00:01:30.223
AN IMPORTANT PART OF MEDICINE

00:01:30.290 --> 00:01:30.623
NOW?

00:01:30.690 --> 00:01:32.425
>> IMPORTANT IN HOW IT IS

00:01:32.492 --> 00:01:34.194
DEVELOPING AND CHANGING, THE

00:01:34.260 --> 00:01:35.862
MODALITY ALLOWS US TO GO FROM

00:01:35.929 --> 00:01:41.835
TREATING THE SYMPTOMS OF DISEASE

00:01:41.901 --> 00:01:43.603
TO CURING THE DISEASE.

00:01:43.670 --> 00:01:45.638
IN USING A CELLULAR PIECE INTO

00:01:45.705 --> 00:01:47.807
THE HUMAN BODY, THE BODY ITSELF

00:01:47.874 --> 00:01:49.175
WILL START TO CURE THE RARE

00:01:49.242 --> 00:01:50.343
INDICATION OF THE DISEASE THEY

00:01:50.410 --> 00:01:50.844
HAVE

00:01:50.910 --> 00:01:52.278
>> OKAY.

00:01:52.345 --> 00:01:57.617
I UNDERSTAND GENEZEN HAS TWO BIG

00:01:57.684 --> 00:01:59.486
FOCUSES, BUILDING AND HIRING.

00:01:59.552 --> 00:02:01.421
DAYS AGO YOU HOPED YOUR NEW LAB

00:02:01.488 --> 00:02:04.290
IN FISHERS, PART OF YOUR

00:02:04.357 --> 00:02:05.058
$40 MILLION EXPANSION.

00:02:05.124 --> 00:02:06.860
TELL US ABOUT THAT LAB, AND WHAT

00:02:06.926 --> 00:02:07.660
YOU'RE DOING THERE.

00:02:07.727 --> 00:02:09.429
>> SO BASICALLY THE NEW LAB THAT

00:02:09.496 --> 00:02:12.665
WE JUST OPENED UP A COUPLE WEEKS

00:02:12.732 --> 00:02:16.202
AGO IS FORMERLY AROUND

00:02:16.269 --> 00:02:17.537
ANALYTICAL AND METHODICAL

00:02:17.604 --> 00:02:17.837
DEVELOPMENT.

00:02:17.904 --> 00:02:19.205
THE VIRAL VECTOR IS THE WAY THAT

00:02:19.272 --> 00:02:21.307
WE WOULD TAKE A GENE AND INSERT

00:02:21.374 --> 00:02:23.476
IT INTO A CELL AND ALLOW THE

00:02:23.543 --> 00:02:24.110
THERAPY TO BE MADE.

00:02:24.177 --> 00:02:26.012
WE'RE BASICALLY PUTTING THE

00:02:26.079 --> 00:02:29.382
FIRST STAGES OF THE CENTER OF OF

00:02:29.449 --> 00:02:31.184
EXCELLENCE TOGETHER.

00:02:31.251 --> 00:02:33.386
OUR ANALYTICAL AND DEVELOPMENT

00:02:33.453 --> 00:02:36.189
TEAM, PEOPLE, PROCESSES, THEY'RE

00:02:36.256 --> 00:02:38.024
VERY EXCITING TIME FOR THE

00:02:38.091 --> 00:02:38.358
TEAMS.

00:02:38.424 --> 00:02:41.928
>> PART OF THAT CENTER OF

00:02:41.995 --> 00:02:43.363
EXCELLENCE, A NEW HIGH TECH

00:02:43.429 --> 00:02:44.197
MANUFACTURING FACILITY COMING

00:02:44.264 --> 00:02:46.966
ON, EXPLAIN WHAT YOU'LL BE DOING

00:02:47.033 --> 00:02:47.901
IN THAT PRODUCTION AREA.

00:02:47.967 --> 00:02:50.103
>> SO, THE PRODUCTION AREA

00:02:50.169 --> 00:02:53.573
MAINLY FOCUSED ON CREATING

00:02:53.640 --> 00:02:56.409
CLINICAL MATERIALS EARLY PHASE

00:02:56.476 --> 00:02:58.678
ONE AND PHASE TWO CLINICAL

00:02:58.745 --> 00:03:00.046
TRIALS, CELL WORKING TYPE

00:03:00.113 --> 00:03:01.080
TREATMENTS, THE KEY PIECE,

00:03:01.147 --> 00:03:02.382
BECAUSE IT IS GOING TO BE MORE

00:03:02.448 --> 00:03:04.250
OF A HIGH TECHNICAL PIECE, THERE

00:03:04.317 --> 00:03:06.386
IS A LOT MORE SEMI AUTOMATED TO

00:03:06.452 --> 00:03:08.154
AUTOMATED SYSTEMS, AND TAKING

00:03:08.221 --> 00:03:09.556
THINGS FROM A MANUAL OPERATION

00:03:09.622 --> 00:03:11.391
AND PUTTING IT INTO SOMETHING

00:03:11.457 --> 00:03:13.660
THAT WILL BE MORE REACTOR BASED

00:03:13.726 --> 00:03:15.728
OR SCALABLE BASE, SO THE DRUG

00:03:15.795 --> 00:03:16.729
PRODUCTS THEMSELVES BECOME

00:03:16.796 --> 00:03:18.064
CHEAPER AS THEY'RE BEING

00:03:18.131 --> 00:03:18.398
MANUFACTURED.

00:03:18.464 --> 00:03:20.300
>> I KNOW YOU GOT A LOT OF

00:03:20.366 --> 00:03:21.467
CONSTRUCTION CREWS BUSY AT YOUR

00:03:21.534 --> 00:03:22.802
OFFICE RIGHT NOW.

00:03:22.869 --> 00:03:24.304
YOU SAID OTHER KEY FOCUS IS

00:03:24.370 --> 00:03:24.604
HIRING.

00:03:24.671 --> 00:03:25.471
I KNOW YOU'RE PRETTY EXCITED

00:03:25.538 --> 00:03:26.105
ABOUT THIS.

00:03:26.172 --> 00:03:28.675
YOU PLAN TO ADD ABOUT 60 JOBS BY

00:03:28.741 --> 00:03:29.809
THE END OF 2023.

00:03:29.876 --> 00:03:32.245
TELL US A LITTLE BIT MORE ABOUT

00:03:32.312 --> 00:03:34.714
THAT HIRING EFFORT.

00:03:34.781 --> 00:03:36.516
>> SO THE HIRING EFFORT IS GOING

00:03:36.583 --> 00:03:37.350
STRONG.

00:03:37.417 --> 00:03:39.586
WHEN I STARTED HERE I THINK I

00:03:39.652 --> 00:03:40.587
WAS NUMBER 11.

00:03:40.653 --> 00:03:42.589
BY THE END OF THIS MONTH WE'RE

00:03:42.655 --> 00:03:43.823
GOING TO BE OVER 40 PEOPLE.

00:03:43.890 --> 00:03:46.392
THE REALITY IS WE HAVE A HIGH

00:03:46.459 --> 00:03:48.728
PROBABILITY OF BEING OVER 70 TO

00:03:48.795 --> 00:03:51.598
75 PEOPLE BY THE END OF THIS

00:03:51.664 --> 00:03:52.298
COMING YEAR.

00:03:52.365 --> 00:03:53.933
THE KEY THING WE'RE LOOKING AT

00:03:54.000 --> 00:03:55.501
BRINGING IN A BUNCH OF

00:03:55.568 --> 00:03:57.503
INDIVIDUALS THAT LOVE THE

00:03:57.570 --> 00:03:58.271
MANUFACTURING ENVIRONMENT FOR

00:03:58.338 --> 00:04:00.139
BIO TECH, BRINGING A LOT OF

00:04:00.206 --> 00:04:02.508
TECHNICAL EXPERTS, SOME ARE

00:04:02.575 --> 00:04:04.110
HOMEGROWN, AND WE'RE LOOKING AT

00:04:04.177 --> 00:04:05.078
COLLEGES AND UNIVERSITIES TO

00:04:05.144 --> 00:04:07.580
BRING IN THE SCIENCE BASED

00:04:07.647 --> 00:04:07.880
INDIVIDUALS.

00:04:07.947 --> 00:04:09.582
IT'S A GREAT OPPORTUNITY FOR US

00:04:09.649 --> 00:04:11.217
TO REALLY SEE WHAT INDIANA HAS

00:04:11.284 --> 00:04:13.252
TO OFFER HERE AND ALSO BRING IN

00:04:13.319 --> 00:04:15.588
ADDITIONAL PEOPLE TO THIS TYPE

00:04:15.655 --> 00:04:16.956
OF ENVIRONMENT.

00:04:17.023 --> 00:04:18.324
>> ONLY BEEN 30 SECONDS LEFT,

00:04:18.391 --> 00:04:18.825
RAY.

00:04:18.891 --> 00:04:21.027
IF YOU CAN TELL US HOW COVID

00:04:21.094 --> 00:04:22.695
IMPACTED YOUR BUSINESS, IT

00:04:22.762 --> 00:04:25.064
REALLY ADVANCED TECHNOLOGY IN

00:04:25.131 --> 00:04:26.199
THE CELL AND GENE THERAPY AREA.

00:04:26.265 --> 00:04:29.502
>> IN ESSENCE, CELL AND GENE

00:04:29.569 --> 00:04:31.137
THERAPY HAD A VERY RAPID START

00:04:31.204 --> 00:04:32.105
WITH COVID.

00:04:32.171 --> 00:04:33.172
WE WERE ALREADY SEEING SUCCESS

00:04:33.239 --> 00:04:34.207
PRIOR TO THAT.

00:04:34.273 --> 00:04:35.441
BUT NOW THAT WE'VE ACTUALLY SEEN

00:04:35.508 --> 00:04:39.312
HOW SOME OF THE THERAPIES HERE

00:04:39.379 --> 00:04:40.480
AND LIFE SCIENCE THERAPIES

00:04:40.546 --> 00:04:44.384
HAVE -- WE DO SEE AN UPSWELL IN

00:04:44.450 --> 00:04:46.285
FUNDING, EXCITEMENT IN THE

00:04:46.352 --> 00:04:47.720
INDUSTRY ITSELF, FROM AN

00:04:47.787 --> 00:04:48.488
INVESTMENT COMMUNITY AS WELL AS

00:04:48.554 --> 00:04:51.290
FROM A PATIENT SIDE OF IT.

00:04:51.357 --> 00:04:53.192
TO SEE MORE THERAPIES ADVANCE AT

00:04:53.259 --> 00:04:54.327
A VERY RAPID RATE.

00:04:54.394 --> 00:04:56.362
THE BIGGEST CHANGE IS THE

00:04:56.429 --> 00:04:57.563
EXPECTATIONS OF A CLINICAL TRIAL

00:04:57.630 --> 00:04:59.732
AND A PRODUCT TAKING TEN YEARS

00:04:59.799 --> 00:05:01.834
HAS BEEN MOVED FROM 18 TO 24

00:05:01.901 --> 00:05:02.168
MONTHS.

00:05:02.235 --> 00:05:04.337
WE SEE SUPPLY CHAIN CONSTRAINTS,

00:05:04.404 --> 00:05:05.538
BECAUSE EVERYBODY IS INTO IT.

00:05:05.605 --> 00:05:06.939
THE REALITY, IF YOU PLAN

00:05:07.006 --> 00:05:08.007
EFFECTIVELY AND START WORKING

00:05:08.074 --> 00:05:09.475
THROUGH CUSTOMERS EARLY, YOU CAN

00:05:09.542 --> 00:05:11.010
HEAD OFF A LOT OF THOSE THINGS.

00:05:11.077 --> 00:05:12.745
A LOT OF GREAT ADVANCES BUT ALSO

00:05:12.812 --> 00:05:14.747
A LOT OF GREAT FUNDING AND

00:05:14.814 --> 00:05:16.049
INTEREST FROM PEOPLE AND

00:05:16.115 --> 00:05:17.684
PATIENTS TO START SEEING HOW

00:05:17.750 --> 00:05:18.718
THIS THERAPY WILL ADVANCE

00:05:18.785 --> 00:05:20.086
>> RAY, CONGRATULATIONS ON THE

00:05:20.153 --> 00:05:21.154
GROWTH.